4/A//SEC Filing
KNUDSON MARK B 4/A
Accession 0001181431-11-018886
CIK 0001371217other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 9:31 AM ET
Size
23.9 KB
Accession
0001181431-11-018886
Insider Transaction Report
Form 4/AAmended
EnteroMedics IncETRM
KNUDSON MARK B
DirectorChrmn, Pres & CEO
Transactions
- Award
Stock Option (right to buy)
2011-02-16+350,000→ 350,000 totalExercise: $2.58From: 2011-03-16Exp: 2021-02-16→ Common Stock (350,000 underlying)
Holdings
- 1,382(indirect: By Trust)
Common Stock
- 337(indirect: By Trust)
Warrants (right to buy)
Exercise: $23.68Exp: 2010-11-13→ Common Stock (337 underlying) - 5,498(indirect: By Trust)
Warrant (Right to Buy)
Exercise: $8.28From: 2009-08-24Exp: 2013-02-24→ Common Stock (5,498 underlying) - 3,215(indirect: By Partnership)
Common Stock
- 57,571(indirect: By Trust)
Common Stock
- 33,432
Stock Option (right to buy)
Exercise: $1.90From: 2010-10-29Exp: 2017-10-29→ Common Stock (33,432 underlying) - 44,131
Stock Option (right to buy)
Exercise: $1.90From: 2010-10-29Exp: 2017-10-29→ Common Stock (44,131 underlying) - 50,472
Stock Option (right to buy)
Exercise: $1.90From: 2010-10-29Exp: 2017-10-29→ Common Stock (50,472 underlying) - 169(indirect: By Trust)
Warrants (right to buy)
Exercise: $23.68Exp: 2010-11-13→ Common Stock (169 underlying) - 11,575
Stock Option (right to buy)
Exercise: $2.76From: 2004-08-16Exp: 2014-08-16→ Common Stock (11,575 underlying) - 25,000
Warrant (Common Stock)
Exercise: $2.19→ Common Stock (25,000 underlying) - 7,915
Stock Option (right to buy)
Exercise: $2.76Exp: 2015-04-27→ Common Stock (7,915 underlying) - 6,776
Stock Option (right to buy)
Exercise: $2.76From: 2007-04-20Exp: 2016-04-20→ Common Stock (6,776 underlying) - 25,902
Stock Option (right to buy)
Exercise: $1.90From: 2010-10-29Exp: 2017-10-29→ Common Stock (25,902 underlying) - 20,833
Stock Option (right to buy)
Exercise: $3.78From: 2009-11-18Exp: 2019-11-18→ Common Stock (20,833 underlying)
Footnotes (10)
- [F1]32,968 shares vest immediately, of the remaining shares 25% vest on the first anniversary of the date of grant and thereafter at 1/36th per month for 36 months, beginning the date shown.
- [F10]This filing is amended to correct the initial exercise date.
- [F2]Currently 100% vested in accordance with achievement of milestone vesting terms.
- [F3]Vests 25% on the first anniversary of the date of grant and 1/36th per month for 36 months thereafter, beginning the date shown.
- [F4]Immediately exercisable.
- [F5]25% vests immediately and the remaining 75% vests on 11/15/2010; 100% of unvested shares become vested upon change in control.
- [F6]Options vest 33% on date noted and thereafter at 1/24th per month.
- [F7]Warrant becomes exercisable 181 days from the date of issuance at close of offering.
- [F8]Warrant expires five years from the date it becomes exercisable.
- [F9]Vests in increments of 1/48th per month, beginning the date shown.
Documents
Issuer
EnteroMedics Inc
CIK 0001371217
Entity typeother
Related Parties
1- filerCIK 0001243513
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 9:31 AM ET
- Size
- 23.9 KB